Concepedia

Emaan Rashidi

ER

Statistics

Publications

5

Citations

277

H-Index

5

Active since

2020

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

IQVIA (United States)

Emaan Rashidi is an author at Johns Hopkins University specializing in drug discovery, substance abuse, and drug toxicity.

ORCID

Top concepts

Publications per year

2020–2025

5

Publications

5

Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011–2016

Ju Nyeong Park, Emaan Rashidi, Kathryn Foti et al. · Drug and Alcohol Dependence · 2020 · 123 citations · Full text

, , +17

Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

Claudia A. Salinas, Anthony Louder, Jennifer M. Polinski et al. · Rheumatology and Therapy · 2022 · 95 citations · Full text

Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States

Hemalkumar B. Mehta, Huijun An, Kathleen M. Andersen et al. · Annals of Internal Medicine · 2021 · 32 citations · Full text

Characteristics of Copayment Offsets for Prescription Drugs in the United States

Aditi P. Sen, So-Yeon Kang, Emaan Rashidi et al. · JAMA Internal Medicine · 2021 · 17 citations · Full text

Establishing a hereditary angioedema prevalence for the United States using a large administrative claims database

Anthony J. Castaldo, Karen Wells, Emaan Rashidi et al. · Annals of Allergy Asthma & Immunology · 2025 · 10 citations · Full text

1–5 of 5